Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )
Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) have?
Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) has 20 citations in the OpenAlex counts ScholarIQ stores.
When was Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) published?
Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) has 2017 year in the ScholarIQ index.
What is the open-access status of Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )?
Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) has hybrid oa status in the ScholarIQ index.
What is the DOI of Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )?
The DOI for Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) is on the source record.
What is the PMID of Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )?
The PMID for Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) is on the source record.
What is the OpenAlex record for Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )?
The OpenAlex for Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> ) is on the source record.